相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
Gianfranco Spiteri et al.
EUROSURVEILLANCE (2020)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Economic impacts of Wuhan 2019-nCoV on China and the world
Foster K. Ayittey et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
Huijun Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor
Giwan Seo et al.
ACS NANO (2020)
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Timothy R. Abbott et al.
CELL (2020)
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
Gregory D. Sempowski et al.
CELL (2020)
The Architecture of SARS-CoV-2 Transcriptome
Dongwan Kim et al.
CELL (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
Daniel Wrapp et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Rational Vaccine Design in the Time of COVID-19
Dennis R. Burton et al.
CELL HOST & MICROBE (2020)
Identification of Human Single-Domain Antibodies against SARS-CoV-2
Yanling Wu et al.
CELL HOST & MICROBE (2020)
SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence
Leonardo Setti et al.
ENVIRONMENTAL RESEARCH (2020)
Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples
Julia Alcoba-Florez et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Stopping the Spread of COVID-19
Angel N. Desai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
SARS-CoV-2 productively infects human gut enterocytes
Mart M. Lamers et al.
SCIENCE (2020)
Rapid repurposing of drugs for COVID-19
R. Kiplin Guy et al.
SCIENCE (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
A strategic approach to COVID-19 vaccine R&D
Lawrence Corey et al.
SCIENCE (2020)
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2
Jianzhong Shi et al.
SCIENCE (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang et al.
TRENDS IN IMMUNOLOGY (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
An injectable photopolymerized hydrogel with antimicrobial and biocompatible properties for infected skin regeneration
Ao Sun et al.
NPG ASIA MATERIALS (2020)
Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence
Kapil Khambholja et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
Ping Liu et al.
PLOS PATHOGENS (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann et al.
LANCET (2020)
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Roy M. Anderson et al.
LANCET (2020)
ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens
Tao Suo et al.
EMERGING MICROBES & INFECTIONS (2020)
Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia
Leon Caly et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Could nasal nitric oxide help to mitigate the severity of COVID-19?
Jan Martel et al.
MICROBES AND INFECTION (2020)
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
Mingxing Huang et al.
NATIONAL SCIENCE REVIEW (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Denisa Bojkova et al.
NATURE (2020)
Viral and host factors related to the clinical outcome of COVID-19
Xiaonan Zhang et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals
Yuan Liu et al.
NATURE (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins
Tommy Tsan-Yuk Lam et al.
NATURE (2020)
Massively multiplexed nucleic acid detection with Cas13
Cheri M. Ackerman et al.
NATURE (2020)
HOW DOES COVID-19 KILL? UNCERTAINTY HAMPERS DOCTORS' ABILITY TO CHOOSE TREATMENTS
Heidi Ledford
NATURE (2020)
Infection of dogs with SARS-CoV-2
Thomas H. C. Sit et al.
NATURE (2020)
Drug researchers pursue new lines of attack against COVID-19
Charlotte Harrison
NATURE BIOTECHNOLOGY (2020)
CRISPR-Cas12-based detection of SARS-CoV-2
James P. Broughton et al.
NATURE BIOTECHNOLOGY (2020)
COVID-19 in humanitarian settings and lessons learned from past epidemics
Ling San Lau et al.
NATURE MEDICINE (2020)
Artificial intelligence-enabled rapid diagnosis of patients with COVID-19
Xueyan Mei et al.
NATURE MEDICINE (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2
Wei E. Huang et al.
MICROBIAL BIOTECHNOLOGY (2020)
COVID-19 brings drug development to a halt
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2020)
Mechano-genomic regulation of coronaviruses and its interplay with ageing
Caroline Uhler et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Covid-19 in South Korea - Challenges of Subclinical Manifestations
Joon-Young Song et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Spread of SARS-CoV-2 in the Icelandic Population
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19
Monica Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Developing Covid-19 Vaccines at Pandemic Speed
Nicole Lurie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Transmission of SARS-CoV-2 in Domestic Cats
Peter J. Halfmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
Firas A. Rabi et al.
PATHOGENS (2020)
Exportin 1 inhibition as antiviral therapy
Md Hafiz Uddin et al.
DRUG DISCOVERY TODAY (2020)
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community
Zichao Luo et al.
RESEARCH (2020)
Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Gun-Soo Park et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
So Young Kim et al.
ANTIVIRAL RESEARCH (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
STEROID IS FIRST DRUG SHOWN TO PREVENT DEATHS FROM COVID-19
Heidi Ledford
NATURE (2020)
COVID-19 vaccines start moving into advanced trials
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2020)
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Identifying airborne transmission as the dominant route for the spread of COVID-19
Renyi Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Big studies dim hopes for hydroxychloroquine
Kai Kupferschmidt
SCIENCE (2020)
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Achille Broggi et al.
SCIENCE (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
Supriya Ravichandran et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
Mizuki Yamamoto et al.
VIRUSES-BASEL (2020)
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
Huibin Lv et al.
CELL REPORTS (2020)
Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection
Stylianos Bournazos et al.
NATURE (2020)
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients
Claudia Alteri et al.
PLOS ONE (2020)
The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET
Chuang Liu et al.
STRUCTURE (2020)
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Leo Hanke et al.
NATURE COMMUNICATIONS (2020)
Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR
Ioanna Smyrlaki et al.
NATURE COMMUNICATIONS (2020)
Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step
Emily A. Bruce et al.
PLOS BIOLOGY (2020)
The immunology of COVID-19: is immune modulation an option for treatment?
Jixin Zhong et al.
LANCET RHEUMATOLOGY (2020)
Multiorgan and Renal Tropism of SARS-CoV-2
Victor G. Puelles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia
Ling Lin et al.
EMERGING MICROBES & INFECTIONS (2020)
Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2
Yun Hee Baek et al.
EMERGING MICROBES & INFECTIONS (2020)
Multifunctional sonosensitizers in sonodynamic cancer therapy
Subin Son et al.
CHEMICAL SOCIETY REVIEWS (2020)
Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies
P. Aaby et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Viral Metagenomics Revealed Sendai Virus and Coronavirus Infection of Malayan Pangolins (Manis javanica)
Ping Liu et al.
VIRUSES-BASEL (2019)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski et al.
MBIO (2018)
The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field
Johan van Griensven et al.
CLINICAL INFECTIOUS DISEASES (2016)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Fc receptors in antibody-dependent enhancement of viral infections
Adam Taylor et al.
IMMUNOLOGICAL REVIEWS (2015)
Cell-based antiviral screening against coronaviruses: Developing virus-specific and broad-spectrum inhibitors
Andy Kilianski et al.
ANTIVIRAL RESEARCH (2014)
Live Vaccine Against Measles, Mumps, and Rubella and the Risk of Hospital Admissions for Nontargeted Infections
Signe Sorup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research
Graham Simmons et al.
ANTIVIRAL RESEARCH (2013)
Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes
NJ Temperton et al.
EMERGING INFECTIOUS DISEASES (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
分享论文
